雲南白藥(000538.SZ)簽署雲南白藥上海國際中心投資協議書
格隆匯6月19日丨雲南白藥(000538.SZ)公佈,公司擬與上海市經濟和信息化委員會(以下簡稱“市經信委”)、上海市閔行區人民政府簽署《投資協議書》,旨在通過上海的平台優勢助力推動公司生物醫藥大健康產業向高端化、智能化、國際化發展,將擬新設的雲南白藥上海國際中心有限責任公司(以下簡稱“項目公司”)工商註冊及税務登記至閔行區南虹橋區域內,承擔地塊開發建設運營等職責,用於建設雲南白藥上海國際中心項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.